Medication adherence in HIV-positive patients with diabetes or hypertension: A focus group study

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Monroe, Anne K ^a,b   Rowe, Tashi L ^a,c   Moore, Richard D ^a,b   Chander, Geetanjali ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of General Internal Medicine   (United States)

^c Research Program Coordinator   (United States)

Author keywords

Adherence; Diabetes; HIV; Hypertension

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADDICTION; ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFORMATION PROCESSING; MALE; MEDICATION COMPLIANCE; MENTAL DISEASE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; COMPLICATION; HIV SEROPOSITIVITY; PSYCHOLOGY;

ADULT; ANTI-HIV AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOCUS GROUPS; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS;

EID: 84888089472     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-488     Document Type: Article

References (34)

1. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Sterne JAC, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins J, Egger M, Lancet 2005 366 378 384 (Pubitemid 41073955)
2. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Barbaro G, Am J Ther 2006 13 248 260 (Pubitemid 44026193)
3. Incidence and risk factors for New-onset diabetes in HIV-infected patients. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A, Diabetes Care 2008 31 1224 1229
4. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS, Arch Intern Med 2005 165 1179 1184 (Pubitemid 40720744)
5. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. Baekken M, Os I, Sandvik L, Oektedalen O, J Hypertens 2008 26 2126 2133
6. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR Jr, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P, OAR Working Group on HIV and Aging, J Acquir Immune Defic Syndr 2012 60 1 S18
7. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. Vance DE, Mugavero M, Willig J, Raper JL, Saag MS, J Assoc Nurses AIDS Care 2011 22 17 25
8. Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes. Batchelder AW, Gonzalez JS, Berg KM, J Behav Med 2013 Epub
9. Dramatic decline in the HIV-1 RNA level over calendar time in a large Urban HIV practice. Moore RD, Bartlett JG, Clin Infect Dis 2011 53 600 604
10. Doing Qualitative Research Thousand Oaks, CA: Sage Publications, Crabtree BF, Miller WL, 2 1999
11. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ, Clin Infect Dis 2011 52 6 793 800
12. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. Hall HI, Frazier EL, Rhodes P, et al. JAMA Int Med. 2013 173 1337 1344
13. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB, J Gen Intern Med 2004 19 1096 1103 (Pubitemid 39552579)
14. How much time do patients with diabetes spend on self-care? Safford MM, Russell L, Suh DC, Roman S, Pogach L, J Am Board Fam Pract 2005 18 262 270 (Pubitemid 41663997)
15. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL, Health Psychol 2000 19 124 133
16. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW, AIDS Care 2000 12 255 266 (Pubitemid 30426745)
17. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Miller LG, Liu H, Hays RD, Golin CE, Ye Z, Beck CK, Kaplan AH, Wenger NS, Clin Infect Dis 2003 36 514 518 (Pubitemid 36241321)
18. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu V, AIDS Care 1996 8 261 270
19. The relationship of disease severity, health beliefs and medication adherence among HIV patients. Gao X, Nau D, Rosenbluth S, Scott V, Woodward C, AIDS Care 2000 12 387 398 (Pubitemid 30618183)
20. Long-term trends in adherence to antiretroviral therapy from start of HAART. Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN, AIDS 2010 24 1153 1162
21. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. Schönnesson LN, Diamond P, Ross M, Williams M, Bratt G, AIDS Care 2006 18 246 253
22. Common-sense models of illness: the example of hypertension. Meyer D, Leventhal H, Gutmann M, Health Psychol 1985 4 115 135
23. The impact of comorbid chronic conditions on diabetes care. Piette J, Kerr E, Diabetes Care 2006 29 725 731 (Pubitemid 44115387)
24. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Horne R, Weinman J, Hankins M, Pyschol Health 1999 14 1 24
25. Physicians' communication of the common-sense self-regulation model results in greater reported adherence than physicians' use of interpersonal skills. Phillips LA, Leventhal H, Leventhal EA, Br J Health Psychol 2012 17 244 257
26. Pill burden in HIV infection: 20 years of experience. Krentz HB, Cosman I, Lee K, Ming JM, Gill MJ, Antivir Ther 2012 17 833 840
27. Predictors of self-reported adherence in persons living with HIV disease. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell-Cope GM, Inouye J, Henry SB, Nicholas PK, Portillo CJ, AIDS Patient Care STDS 1999 13 185 197 (Pubitemid 29155987)
28. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Gonzalez JS, Batchelder AW, Psaros C, Safren SA, J Acquir Immune Defic Syndr 2011 58 181 187
29. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE, AIDS 2002 16 2175 2182 (Pubitemid 35387272)
30. A prospective study of predictors of adherence to combination antiretroviral medication. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH, Wenger NS, J Gen Intern Med 2002 17 756 765 (Pubitemid 35286241)
31. HIV in the united states: at a glance. Centers for disease control and prevention (CDC). [ http://www.cdc.gov/hiv/resources/factsheets/us.htm ]
32. National diabetes information clearinghouse, National Institute of Diabetes and Digestigve and Kidney Diseases (NIDDK). National Diabetes Statistics, 2011 [ http://diabetes.niddk.nih.gov/dm/pubs/statistics/ ]
33. High blood pressure facts. Centers for disease control and prevention (CDC). [ http://www.cdc.gov/bloodpressure/facts.htm ]
34. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of health and human services. 2013 1 K6 Available at http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0#